79% year-on-year increase in net revenue
In 2023, LiveSpo recorded a 79% year-on-year growth in net revenue. This performance was attributed to the company’s effort to (i) increase the number of product types distributed in the three largest pharmacy chains in Vietnam, and (ii) have effective promotion activities selling directly to end-users on e-commerce platforms.
LiveSpo, founded by three founders with combined experience in biotechnology, sales, and marketing, is a consumer health company manufacturing and selling liquid spore-based probiotics supplements, focusing on improving digestive health and enhancing respiratory function. Its nasal-spray spore probiotics, LiveSpo Navax, is one of LiveSpo’s most popular and highly efficacious products, offering a safe respiratory treatment option to patients, particularly children, instead of using antibiotics.